65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79722D0153
Awardee
Awarding agency
Task orders
3

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 86% complete
IDV ceiling
$3,500,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Calliditas Therapeutics US Inc. (UEI: MAZGQDV5PK59) holds a multiple-award Federal Supply Schedule contract valued at $3.5 million, awarded by Veterans Integrated Service Network 12 on July 1, 2022, with an ultimate completion date of June 30, 2027. The contract is structured under the Pharmaceuticals and Drugs schedule (FSS-61-IB) for the procurement of TARPEYO, a specialized pharmaceutical product indicated for the treatment of primary immunoglobulin A nephropathy in adult patients with uncontrolled proteinuria. The contract employs no set-aside provisions, reflecting the specialized and limited-source nature of this therapeutic intervention. The company also holds a single-award Blanket Purchase Agreement valued at $1.75 million awarded by the Department of Veterans Affairs' National Acquisition Center on April 4, 2023, extending through April 3, 2027, which designates Calliditas Therapeutics as the sole approved supplier of TARPEYO to Veterans Affairs medical facilities nationwide. Both indefinite delivery vehicles are firm fixed-price arrangements with delivery orders issued against them.

As of the record date, three delivery orders have been issued under the Federal Supply Schedule contract against Veterans Integrated Service Network 20, including orders valued at $10,637.43 (awarded February 20, 2024, completion May 20, 2024), $127,649.15 (awarded March 12, 2024, completion March 11, 2025), and $261,527.52 (awarded March 12, 2025, completion March 11, 2026), demonstrating ongoing utilization for supplying TARPEYO to VA medical facilities. The place of performance for these orders is Cary, North Carolina 27513. These contracts support the Department of Veterans Affairs' mission to ensure reliable access to this specialized medication for eligible veteran patients diagnosed with primary immunoglobulin A nephropathy across the VA's integrated service networks, addressing a serious renal condition requiring targeted therapeutic intervention.

Task orders

Task order Ordering agency Obligated Awarded
Bulk tarpeyo 36C26025F0063 Veterans Integrated Service Network 20 (VHA) $0
Tarpeyo 36C26024F0271 Veterans Integrated Service Network 20 (VHA) $127,649
Tarpeyo 36C26024F0241 Veterans Integrated Service Network 20 (VHA) $10,637

IDV awards

IDV Agency Ceiling Awarded
36E79723A0013 BPA for tarpeyo National Acquisition Center (VA) $1,750,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 · 2026 PL. $0
Supplemental Agreement for work within scope P00007 · 2025 PL updates. $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 · POC update. $0
Supplemental Agreement for work within scope P00004 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00003 · 2024 PL updates. $0
Supplemental Agreement for work within scope P00002 · 2023 PL update. $0
Supplemental Agreement for work within scope P00001 · Temp to perm LCC. $0
Original award $0

Quick answers

Who was awarded contract 36F79722D0153?

36F79722D0153 was awarded to Calliditas Therapeutics US Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 1, 2022.

How much is contract 36F79722D0153 worth?

36F79722D0153's own ceiling is $3,500,000.

How many orders have been placed under contract 36F79722D0153?

3 orders have been placed under 36F79722D0153, the latest on March 12, 2025.

Who can order from contract 36F79722D0153?

36F79722D0153 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79722D0153 part of a contract vehicle?

Yes. 36F79722D0153 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79722D0153 competed?

The extent of competition for 36F79722D0153 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV